Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 148

1.

Diagnostic Performance of Neurofilaments in Chinese Patients With Amyotrophic Lateral Sclerosis: A Prospective Study.

Li DW, Ren H, Jeromin A, Liu M, Shen D, Tai H, Ding Q, Li X, Cui L.

Front Neurol. 2018 Aug 28;9:726. doi: 10.3389/fneur.2018.00726. eCollection 2018.

2.

Glial fibrillary acidic protein elevations relate to neuroimaging abnormalities after mild TBI.

Gill J, Latour L, Diaz-Arrastia R, Motamedi V, Turtzo C, Shahim P, Mondello S, DeVoto C, Veras E, Hanlon D, Song L, Jeromin A.

Neurology. 2018 Oct 9;91(15):e1385-e1389. doi: 10.1212/WNL.0000000000006321. Epub 2018 Sep 12.

PMID:
30209234
3.

Elevated tau and interleukin-6 concentrations in adults with obstructive sleep apnea.

Motamedi V, Kanefsky R, Matsangas P, Mithani S, Jeromin A, Brock MS, Mysliwiec V, Gill J.

Sleep Med. 2018 Mar;43:71-76. doi: 10.1016/j.sleep.2017.11.1121. Epub 2017 Nov 24.

4.

Recommendations of the Global Multiple System Atrophy Research Roadmap Meeting.

Walsh RR, Krismer F, Galpern WR, Wenning GK, Low PA, Halliday G, Koroshetz WJ, Holton J, Quinn NP, Rascol O, Shaw LM, Eidelberg D, Bower P, Cummings JL, Abler V, Biedenharn J, Bitan G, Brooks DJ, Brundin P, Fernandez H, Fortier P, Freeman R, Gasser T, Hewitt A, Höglinger GU, Huentelman MJ, Jensen PH, Jeromin A, Kang UJ, Kaufmann H, Kellerman L, Khurana V, Klockgether T, Kim WS, Langer C, LeWitt P, Masliah E, Meissner W, Melki R, Ostrowitzki S, Piantadosi S, Poewe W, Robertson D, Roemer C, Schenk D, Schlossmacher M, Schmahmann JD, Seppi K, Shih L, Siderowf A, Stebbins GT, Stefanova N, Tsuji S, Sutton S, Zhang J.

Neurology. 2018 Jan 9;90(2):74-82. doi: 10.1212/WNL.0000000000004798. Epub 2017 Dec 13. Review.

5.

A Multi-site In-depth Evaluation of the Quanterix Simoa from a User's Perspective.

Chunyk AG, Joyce A, Fischer SK, Dysinger M, Mikulskis A, Jeromin A, Lawrence-Henderson R, Baker D, Yeung D.

AAPS J. 2017 Dec 1;20(1):10. doi: 10.1208/s12248-017-0156-7.

PMID:
29196830
6.

Comparison of elevated phosphorylated neurofilament heavy chains in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.

De Schaepdryver M, Jeromin A, Gille B, Claeys KG, Herbst V, Brix B, Van Damme P, Poesen K.

J Neurol Neurosurg Psychiatry. 2018 Apr;89(4):367-373. doi: 10.1136/jnnp-2017-316605. Epub 2017 Oct 20.

PMID:
29054919
7.

Biomarkers in Neurodegenerative Diseases.

Jeromin A, Bowser R.

Adv Neurobiol. 2017;15:491-528. doi: 10.1007/978-3-319-57193-5_20. Review.

PMID:
28674995
8.

Serial Assessment of Gray Matter Abnormalities after Sport-Related Concussion.

España LY, Lee RM, Ling JM, Jeromin A, Mayer AR, Meier TB.

J Neurotrauma. 2017 Nov 15;34(22):3143-3152. doi: 10.1089/neu.2017.5002. Epub 2017 Aug 17.

PMID:
28665173
9.

Phosphorylated neurofilament heavy chain: A biomarker of survival for C9ORF72-associated amyotrophic lateral sclerosis.

Gendron TF; C9ORF72 Neurofilament Study Group, Daughrity LM, Heckman MG, Diehl NN, Wuu J, Miller TM, Pastor P, Trojanowski JQ, Grossman M, Berry JD, Hu WT, Ratti A, Benatar M, Silani V, Glass JD, Floeter MK, Jeromin A, Boylan KB, Petrucelli L.

Ann Neurol. 2017 Jul;82(1):139-146. doi: 10.1002/ana.24980.

10.

Repetitive head impact exposure and later-life plasma total tau in former National Football League players.

Alosco ML, Tripodis Y, Jarnagin J, Baugh CM, Martin B, Chaisson CE, Estochen N, Song L, Cantu RC, Jeromin A, Stern RA.

Alzheimers Dement (Amst). 2016 Dec 10;7:33-40. doi: 10.1016/j.dadm.2016.11.003. eCollection 2017.

11.

Acute plasma tau relates to prolonged return to play after concussion.

Gill J, Merchant-Borna K, Jeromin A, Livingston W, Bazarian J.

Neurology. 2017 Feb 7;88(6):595-602. doi: 10.1212/WNL.0000000000003587. Epub 2017 Jan 6.

12.

A digital enzyme-linked immunosorbent assay for ultrasensitive measurement of amyloid-β 1-42 peptide in human plasma with utility for studies of Alzheimer's disease therapeutics.

Song L, Lachno DR, Hanlon D, Shepro A, Jeromin A, Gemani D, Talbot JA, Racke MM, Dage JL, Dean RA.

Alzheimers Res Ther. 2016 Dec 15;8(1):58.

13.

Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic.

O'Bryant SE, Mielke MM, Rissman RA, Lista S, Vanderstichele H, Zetterberg H, Lewczuk P, Posner H, Hall J, Johnson L, Fong YL, Luthman J, Jeromin A, Batrla-Utermann R, Villarreal A, Britton G, Snyder PJ, Henriksen K, Grammas P, Gupta V, Martins R, Hampel H; Biofluid Based Biomarker Professional Interest Area.

Alzheimers Dement. 2017 Jan;13(1):45-58. doi: 10.1016/j.jalz.2016.09.014. Epub 2016 Nov 18.

14.

Plasma tau in Alzheimer disease.

Mattsson N, Zetterberg H, Janelidze S, Insel PS, Andreasson U, Stomrud E, Palmqvist S, Baker D, Tan Hehir CA, Jeromin A, Hanlon D, Song L, Shaw LM, Trojanowski JQ, Weiner MW, Hansson O, Blennow K; ADNI Investigators.

Neurology. 2016 Oct 25;87(17):1827-1835. Epub 2016 Sep 30.

15.

Fluid Biomarkers of Traumatic Brain Injury and Intended Context of Use.

Bogoslovsky T, Gill J, Jeromin A, Davis C, Diaz-Arrastia R.

Diagnostics (Basel). 2016 Oct 18;6(4). pii: E37. Review.

16.

Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS.

Oeckl P, Jardel C, Salachas F, Lamari F, Andersen PM, Bowser R, de Carvalho M, Costa J, van Damme P, Gray E, Grosskreutz J, Hernández-Barral M, Herukka SK, Huss A, Jeromin A, Kirby J, Kuzma-Kozakiewicz M, Amador Mdel M, Mora JS, Morelli C, Muckova P, Petri S, Poesen K, Rhode H, Rikardsson AK, Robberecht W, Rodríguez Mahillo AI, Shaw P, Silani V, Steinacker P, Turner MR, Tüzün E, Yetimler B, Ludolph AC, Otto M.

Amyotroph Lateral Scler Frontotemporal Degener. 2016 Jul-Aug;17(5-6):404-13. doi: 10.3109/21678421.2016.1167913. Epub 2016 Apr 11.

PMID:
27415180
17.

Increases of Plasma Levels of Glial Fibrillary Acidic Protein, Tau, and Amyloid β up to 90 Days after Traumatic Brain Injury.

Bogoslovsky T, Wilson D, Chen Y, Hanlon D, Gill J, Jeromin A, Song L, Moore C, Gong Y, Kenney K, Diaz-Arrastia R.

J Neurotrauma. 2017 Jan 1;34(1):66-73. doi: 10.1089/neu.2015.4333. Epub 2016 Jul 8.

18.

Plasma β-amyloid in Alzheimer's disease and vascular disease.

Janelidze S, Stomrud E, Palmqvist S, Zetterberg H, van Westen D, Jeromin A, Song L, Hanlon D, Tan Hehir CA, Baker D, Blennow K, Hansson O.

Sci Rep. 2016 May 31;6:26801. doi: 10.1038/srep26801.

19.

Comparing biological markers of Alzheimer's disease across blood fraction and platforms: Comparing apples to oranges.

O'Bryant SE, Lista S, Rissman RA, Edwards M, Zhang F, Hall J, Zetterberg H, Lovestone S, Gupta V, Graff-Radford N, Martins R, Jeromin A, Waring S, Oh E, Kling M, Baker LD, Hampel H.

Alzheimers Dement (Amst). 2015 Dec 29;3:27-34. doi: 10.1016/j.dadm.2015.12.003. eCollection 2016.

20.

Membrane binding of Neuronal Calcium Sensor-1 (NCS1).

Lemire S, Jeromin A, Boisselier É.

Colloids Surf B Biointerfaces. 2016 Mar 1;139:138-47. doi: 10.1016/j.colsurfb.2015.11.065. Epub 2015 Dec 9.

PMID:
26705828
21.

Longitudinal assessment of white matter abnormalities following sports-related concussion.

Meier TB, Bergamino M, Bellgowan PS, Teague TK, Ling JM, Jeromin A, Mayer AR.

Hum Brain Mapp. 2016 Feb;37(2):833-45. doi: 10.1002/hbm.23072. Epub 2015 Dec 10.

PMID:
26663463
22.

Translational Biomarkers of Neurotoxicity: A Health and Environmental Sciences Institute Perspective on the Way Forward.

Roberts RA, Aschner M, Calligaro D, Guilarte TR, Hanig JP, Herr DW, Hudzik TJ, Jeromin A, Kallman MJ, Liachenko S, Lynch JJ 3rd, Miller DB, Moser VC, O'Callaghan JP, Slikker W Jr, Paule MG.

Toxicol Sci. 2015 Dec;148(2):332-40. doi: 10.1093/toxsci/kfv188. Review.

23.

ALS biomarkers for therapy development: State of the field and future directions.

Benatar M, Boylan K, Jeromin A, Rutkove SB, Berry J, Atassi N, Bruijn L.

Muscle Nerve. 2016 Feb;53(2):169-82. doi: 10.1002/mus.24979. Epub 2015 Dec 29. Review.

24.

Assessing the commutability of reference material formats for the harmonization of amyloid-β measurements.

Bjerke M, Andreasson U, Kuhlmann J, Portelius E, Pannee J, Lewczuk P, Umek RM, Vanmechelen E, Vanderstichele H, Stoops E, Lewis J, Vandijck M, Kostanjevecki V, Jeromin A, Salamone SJ, Schmidt O, Matzen A, Madin K, Eichenlaub U, Bittner T, Shaw LM, Zegers I, Zetterberg H, Blennow K.

Clin Chem Lab Med. 2016 Jul 1;54(7):1177-91. doi: 10.1515/cclm-2015-0733.

25.

Recommendations for Use and Fit-for-Purpose Validation of Biomarker Multiplex Ligand Binding Assays in Drug Development.

Jani D, Allinson J, Berisha F, Cowan KJ, Devanarayan V, Gleason C, Jeromin A, Keller S, Khan MU, Nowatzke B, Rhyne P, Stephen L.

AAPS J. 2016 Jan;18(1):1-14. doi: 10.1208/s12248-015-9820-y. Epub 2015 Sep 16. Review.

26.

Peripheral Total Tau in Military Personnel Who Sustain Traumatic Brain Injuries During Deployment.

Olivera A, Lejbman N, Jeromin A, French LM, Kim HS, Cashion A, Mysliwiec V, Diaz-Arrastia R, Gill J.

JAMA Neurol. 2015 Oct;72(10):1109-16. doi: 10.1001/jamaneurol.2015.1383.

PMID:
26237304
27.

Developing a molecular taxonomy for traumatic brain injury: a perspective to enable the development of diagnostics and therapeutics.

Jeromin A, Maas AI, Buki A, Mondello S.

Biomark Med. 2015;9(7):619-21. doi: 10.2217/bmm.15.22. No abstract available.

28.

Fluid biomarkers in multiple system atrophy: A review of the MSA Biomarker Initiative.

Laurens B, Constantinescu R, Freeman R, Gerhard A, Jellinger K, Jeromin A, Krismer F, Mollenhauer B, Schlossmacher MG, Shaw LM, Verbeek MM, Wenning GK, Winge K, Zhang J, Meissner WG.

Neurobiol Dis. 2015 Aug;80:29-41. doi: 10.1016/j.nbd.2015.05.004. Epub 2015 May 15. Review.

PMID:
25982836
29.

Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases.

Lleó A, Cavedo E, Parnetti L, Vanderstichele H, Herukka SK, Andreasen N, Ghidoni R, Lewczuk P, Jeromin A, Winblad B, Tsolaki M, Mroczko B, Visser PJ, Santana I, Svenningsson P, Blennow K, Aarsland D, Molinuevo JL, Zetterberg H, Mollenhauer B.

Nat Rev Neurol. 2015 Jan;11(1):41-55. doi: 10.1038/nrneurol.2014.232. Epub 2014 Dec 16. Review.

PMID:
25511894
30.

Imaging as a biomarker in drug discovery for Alzheimer's disease: is MRI a suitable technology?

Merlo Pich E, Jeromin A, Frisoni GB, Hill D, Lockhart A, Schmidt ME, Turner MR, Mondello S, Potter WZ.

Alzheimers Res Ther. 2014 Jul 30;6(4):51. doi: 10.1186/alzrt276. eCollection 2014. Review.

31.

CSF and plasma amyloid-β temporal profiles and relationships with neurological status and mortality after severe traumatic brain injury.

Mondello S, Buki A, Barzo P, Randall J, Provuncher G, Hanlon D, Wilson D, Kobeissy F, Jeromin A.

Sci Rep. 2014 Oct 10;4:6446. doi: 10.1038/srep06446.

32.

Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research.

O'Bryant SE, Gupta V, Henriksen K, Edwards M, Jeromin A, Lista S, Bazenet C, Soares H, Lovestone S, Hampel H, Montine T, Blennow K, Foroud T, Carrillo M, Graff-Radford N, Laske C, Breteler M, Shaw L, Trojanowski JQ, Schupf N, Rissman RA, Fagan AM, Oberoi P, Umek R, Weiner MW, Grammas P, Posner H, Martins R; STAR-B and BBBIG working groups.

Alzheimers Dement. 2015 May;11(5):549-60. doi: 10.1016/j.jalz.2014.08.099. Epub 2014 Oct 1. Review.

33.

Guidelines for uniform reporting of body fluid biomarker studies in neurologic disorders.

Gnanapavan S, Hegen H, Khalil M, Hemmer B, Franciotta D, Hughes S, Hintzen R, Jeromin A, Havrdova E, Tumani H, Bertolotto A, Comabella M, Frederiksen J, Álvarez-Cermeño JC, Villar L, Galimberti D, Myhr KM, Dujmovic I, Fazekas F, Ionete C, Menge T, Kuhle J, Keir G, Deisenhammer F, Teunissen C, Giovannoni G.

Neurology. 2014 Sep 23;83(13):1210-6. doi: 10.1212/WNL.0000000000000809. Epub 2014 Aug 22.

PMID:
25150289
34.

A high-resolution spatiotemporal atlas of gene expression of the developing mouse brain.

Thompson CL, Ng L, Menon V, Martinez S, Lee CK, Glattfelder K, Sunkin SM, Henry A, Lau C, Dang C, Garcia-Lopez R, Martinez-Ferre A, Pombero A, Rubenstein JLR, Wakeman WB, Hohmann J, Dee N, Sodt AJ, Young R, Smith K, Nguyen TN, Kidney J, Kuan L, Jeromin A, Kaykas A, Miller J, Page D, Orta G, Bernard A, Riley Z, Smith S, Wohnoutka P, Hawrylycz MJ, Puelles L, Jones AR.

Neuron. 2014 Jul 16;83(2):309-323. doi: 10.1016/j.neuron.2014.05.033. Epub 2014 Jun 19.

35.

NCS-1 deficiency causes anxiety and depressive-like behavior with impaired non-aversive memory in mice.

de Rezende VB, Rosa DV, Comim CM, Magno LA, Rodrigues AL, Vidigal P, Jeromin A, Quevedo J, Romano-Silva MA.

Physiol Behav. 2014 May 10;130:91-8. doi: 10.1016/j.physbeh.2014.03.005. Epub 2014 Mar 14.

PMID:
24631552
36.

CSF α-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders.

Mondello S, Constantinescu R, Zetterberg H, Andreasson U, Holmberg B, Jeromin A.

Parkinsonism Relat Disord. 2014 Apr;20(4):382-7. doi: 10.1016/j.parkreldis.2014.01.011. Epub 2014 Jan 22.

PMID:
24507721
37.

Changes in cerebral oxygen saturation correlate with S100B in infants undergoing cardiac surgery with cardiopulmonary bypass.

Abu-Sultaneh S, Hehir DA, Murkowski K, Ghanayem NS, Liedel J, Hoffmann RG, Cao Y, Mitchell ME, Jeromin A, Tweddell JS, Hoffman GM.

Pediatr Crit Care Med. 2014 Mar;15(3):219-28. doi: 10.1097/PCC.0000000000000055.

PMID:
24366505
38.

Developing novel blood-based biomarkers for Alzheimer's disease.

Snyder HM, Carrillo MC, Grodstein F, Henriksen K, Jeromin A, Lovestone S, Mielke MM, O'Bryant S, Sarasa M, Sjøgren M, Soares H, Teeling J, Trushina E, Ward M, West T, Bain LJ, Shineman DW, Weiner M, Fillit HM.

Alzheimers Dement. 2014 Jan;10(1):109-14. doi: 10.1016/j.jalz.2013.10.007. Review.

39.

Calpain cleavage and inactivation of the sodium calcium exchanger-3 occur downstream of Aβ in Alzheimer's disease.

Atherton J, Kurbatskaya K, Bondulich M, Croft CL, Garwood CJ, Chhabra R, Wray S, Jeromin A, Hanger DP, Noble W.

Aging Cell. 2014 Feb;13(1):49-59. doi: 10.1111/acel.12148. Epub 2013 Sep 18.

40.

The future of blood-based biomarkers for Alzheimer's disease.

Henriksen K, O'Bryant SE, Hampel H, Trojanowski JQ, Montine TJ, Jeromin A, Blennow K, Lönneborg A, Wyss-Coray T, Soares H, Bazenet C, Sjögren M, Hu W, Lovestone S, Karsdal MA, Weiner MW; Blood-Based Biomarker Interest Group.

Alzheimers Dement. 2014 Jan;10(1):115-31. doi: 10.1016/j.jalz.2013.01.013. Epub 2013 Jul 11. Review.

41.

The challenge of mild traumatic brain injury: role of biochemical markers in diagnosis of brain damage.

Mondello S, Schmid K, Berger RP, Kobeissy F, Italiano D, Jeromin A, Hayes RL, Tortella FC, Buki A.

Med Res Rev. 2014 May;34(3):503-31. doi: 10.1002/med.21295. Epub 2013 Jun 28. Review.

PMID:
23813922
42.

Spectrin Breakdown Products (SBDPs) as Potential Biomarkers for Neurodegenerative Diseases.

Yan XX, Jeromin A, Jeromin A.

Curr Transl Geriatr Exp Gerontol Rep. 2012 Jun;1(2):85-93.

43.

α-Synuclein in CSF of patients with severe traumatic brain injury.

Mondello S, Buki A, Italiano D, Jeromin A.

Neurology. 2013 Apr 30;80(18):1662-8. doi: 10.1212/WNL.0b013e3182904d43. Epub 2013 Apr 3.

PMID:
23553480
44.

First responder for in-hospital resuscitation: 5-year experience with an automated external defibrillator-based program.

Kloppe C, Jeromin A, Kloppe A, Ernst M, Mügge A, Hanefeld C.

J Emerg Med. 2013 Jun;44(6):1077-82. doi: 10.1016/j.jemermed.2012.11.036. Epub 2013 Feb 16.

PMID:
23419213
45.

Serum biomarkers of MRI brain injury in neonatal hypoxic ischemic encephalopathy treated with whole-body hypothermia: a pilot study.

Massaro AN, Jeromin A, Kadom N, Vezina G, Hayes RL, Wang KK, Streeter J, Johnston MV.

Pediatr Crit Care Med. 2013 Mar;14(3):310-7. doi: 10.1097/PCC.0b013e3182720642.

46.

Alzheimer disease biomarker testing in cerebrospinal fluid: a method to harmonize assay platforms in the absence of an absolute reference standard.

Vanderstichele HM, Shaw L, Vandijck M, Jeromin A, Zetterberg H, Blennow K, Teunissen C, Engelborghs S.

Clin Chem. 2013 Apr;59(4):710-2. doi: 10.1373/clinchem.2012.201830. Epub 2013 Jan 25. No abstract available.

47.

Potential sources of interference on Abeta immunoassays in biological samples.

Vanderstichele H, Stoops E, Vanmechelen E, Jeromin A.

Alzheimers Res Ther. 2012 Oct 17;4(5):39. doi: 10.1186/alzrt142. eCollection 2012. Review.

48.

An anatomically comprehensive atlas of the adult human brain transcriptome.

Hawrylycz MJ, Lein ES, Guillozet-Bongaarts AL, Shen EH, Ng L, Miller JA, van de Lagemaat LN, Smith KA, Ebbert A, Riley ZL, Abajian C, Beckmann CF, Bernard A, Bertagnolli D, Boe AF, Cartagena PM, Chakravarty MM, Chapin M, Chong J, Dalley RA, David Daly B, Dang C, Datta S, Dee N, Dolbeare TA, Faber V, Feng D, Fowler DR, Goldy J, Gregor BW, Haradon Z, Haynor DR, Hohmann JG, Horvath S, Howard RE, Jeromin A, Jochim JM, Kinnunen M, Lau C, Lazarz ET, Lee C, Lemon TA, Li L, Li Y, Morris JA, Overly CC, Parker PD, Parry SE, Reding M, Royall JJ, Schulkin J, Sequeira PA, Slaughterbeck CR, Smith SC, Sodt AJ, Sunkin SM, Swanson BE, Vawter MP, Williams D, Wohnoutka P, Zielke HR, Geschwind DH, Hof PR, Smith SM, Koch C, Grant SGN, Jones AR.

Nature. 2012 Sep 20;489(7416):391-399. doi: 10.1038/nature11405.

49.

Kv4.2 potassium channels segregate to extrasynaptic domains and influence intrasynaptic NMDA receptor NR2B subunit expression.

Kaufmann WA, Matsui K, Jeromin A, Nerbonne JM, Ferraguti F.

Brain Struct Funct. 2013 Sep;218(5):1115-32. doi: 10.1007/s00429-012-0450-1. Epub 2012 Aug 30.

50.

Ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) is increased in cerebrospinal fluid and plasma of patients after epileptic seizure.

Mondello S, Palmio J, Streeter J, Hayes RL, Peltola J, Jeromin A.

BMC Neurol. 2012 Aug 29;12:85. doi: 10.1186/1471-2377-12-85.

Supplemental Content

Loading ...
Support Center